NCT06769139View on ClinicalTrials.gov

Evaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell Disease

Not yet recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Sickle Cell Disease
Interventions
OTHER

Red blood cell exchange

Red blood cell exchange manual exchange and automatized exchange

Trial Locations (1)

31059

Oncopole - Toulouse Hospital, Toulouse

All Listed Sponsors
collaborator

Etablissement Français du Sang

OTHER

lead

University Hospital, Toulouse

OTHER

NCT06769139 - Evaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell Disease | Biotech Hunter | Biotech Hunter